Why it was included in the FDA ban While animal studies suggest that DIHEXA may tout these brain benefits (17), the FDA says it has not identified any human exposure data. Meaning: The safety and efficacy of DIHEXA for humans is still up in the air
Notable Absence of Growth Hormone Side Effects: One of the key safety advantages of AOD-9604 is that it does not produce the side effects commonly associated with full-length growth hormone therapy
GAC media gradually loses its adsorption capacity over time due to the accumulation of particulates, biofilm growth, and physical abrasion
These injections deliver a concentrated dose of vitamins and minerals directly into the bloodstream, bypassing the digestive system
Unfortunately, and ironically with the latest FDA restriction: Only large well-funded companies can afford FDA trials Naturally occurring peptides are hard to patent No patent = no financial incentive No incentive = no approval No approval = no legal compounding Thats the present reality, I hope this regulatory and political standstill will resolved in the coming years
Sermorelin/Ipamorelin Are often combined because they have synergistic properties Research and real-world application have proven them to help slow down the aging process, increase muscle mass, decrease fat mass, reduce inflammation, and heal the gut